Abstract
Purpose
Fatigue is a frequent and common symptom of multiple sclerosis (MS) that can interfere with patients' everyday activities. There is no objective scale for assessing fatigue in French MS patients. The objective of this study was to adapt an English language scale for use with French patients.Methods
The Fatigue Impact Scale was translated and culturally adapted into French by a committee of medical and linguistic specialists. The psychometric properties of this new instrument, called EMIF-SEP were assessed.Results
EMIF-SEP is composed of 40 items. Four dimensions of this scale (cognitive, physical, social role and psychological) were identified by factor analysis. Each dimension had a high internal consistency (Cronbach's alpha >0.80). The test-retest reproducibility was very satisfactory; intra-class correlation coefficients were all above 0.70.Conclusion
EMIF-SEP is the first scale for assessing MS-related fatigue which has been adapted to French-speaking patients. It is useful for clinical practice and MS-related research.References
Articles referenced by this article (32)
Title not supplied
Title not supplied
[Measuring fatigue in patients with multiple sclerosis with standardized methods in German speaking areas].
Fortschr Neurol Psychiatr, (9):497-502 2006
MED: 16947099
Title not supplied
Arch Neurol 1984
Title not supplied
Fatigue associated with multiple sclerosis: diagnosis, impact and management.
Mult Scler, (3):219-227 2003
MED: 12814166
The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus.
Arch Neurol, (10):1121-1123 1989
MED: 2803071
Title not supplied
1998
Show 10 more references (10 of 32)
Citations & impact
Impact metrics
Citations of article over time
Smart citations by scite.ai
Explore citation contexts and check if this article has been
supported or disputed.
https://scite.ai/reports/10.1177/1352458507077942
Article citations
Global prevalence of fatigue in patients with multiple sclerosis: a systematic review and meta-analysis.
Front Neurol, 15:1457788, 02 Oct 2024
Cited by: 0 articles | PMID: 39416662 | PMCID: PMC11479926
Review Free full text in Europe PMC
Validation of the Fatigue Impact Scale in Multiple Sclerosis Patients in Serbia.
Brain Sci, 14(8):825, 17 Aug 2024
Cited by: 0 articles | PMID: 39199516 | PMCID: PMC11352471
The impact of fatigue on people with multiple sclerosis in Morocco.
Afr J Disabil, 13:1376, 31 Jul 2024
Cited by: 0 articles | PMID: 39114452 | PMCID: PMC11304114
Persistence and emergence of new neuropsychological deficits following SARS-CoV-2 infection: A follow-up assessment of the Geneva COVID-COG cohort.
J Glob Health, 14:05008, 08 Mar 2024
Cited by: 3 articles | PMID: 38452292 | PMCID: PMC10919907
Efficacy of dalfampridine in neuromyelitis optica spectrum disorder: A pilot study.
Mult Scler J Exp Transl Clin, 10(1):20552173241233952, 01 Jan 2024
Cited by: 0 articles | PMID: 38435499 | PMCID: PMC10908237
Go to all (37) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.